WNK1 and breast carcinoma: We demonstrate that bone-derived OPN promotes the migration and stem-like properties of breast cancer cells via the cell surface receptor CD44 and RGD-dependent cell surface integrins, resulting in activation of WNK-1 and PRAS40.